Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Brainstorm Cell Therapeutics Inc. (BCLI)

« Back to company index

BCLI Chatter Timeline

Stock Ticker for BCLI

Most Active Tweeters for BCLI

UserTweets
@bulletin_en 3
@whatsonthorold2 3
@thefinreviewer 3
@AmericanBanking 3
@StockTexts 3

Recent Tweets for BCLI

tzack16 @tzack16
$BCLI Early Access to ALS Treatment in Israel https://t.co/aiHcylLIZa $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/0UhPpGfwu0
March 21st 2019, 7:03pm
UlmHi @UlmHi
Reviewing Pain Therapeutics Inc. $BCLI's results https://t.co/Mfa11JXbHj
March 21st 2019, 1:03pm
TheTruthStudio @TheTruthStudio
$BCLI Early Access to ALS Treatment in Israel https://t.co/Y3tTXGH6Ec $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/poxFzuVyUe
March 20th 2019, 11:03pm
zackcapp @zackcapp
$BCLI Early Access to ALS Treatment in Israel https://t.co/WZNWim4GXh $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/5ADgshs1ap
March 20th 2019, 5:03pm
InstitutionalZC @InstitutionalZC
$BCLI Early Access to ALS Treatment in Israel https://t.co/cEjEG1w0kc $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/PISKBdKfjl
March 20th 2019, 3:03pm
bbnsnews @bbnsnews
-$0.10 Earnings Per Share Expected for Brainstorm Cell Therapeutics Inc $BCLI This Quarter https://t.co/SaOc2wUjtD
March 20th 2019, 12:03pm
stocknewstimes @stocknewstimes
Critical Comparison: Brainstorm Cell Therapeutics $BCLI and Atara Biotherapeutics $ATRA https://t.co/WfFNKBuOr3
March 20th 2019, 10:03am
TheMarketsDaily @TheMarketsDaily
Head to Head Review: Brainstorm Cell Therapeutics $BCLI & Atara Biotherapeutics $ATRA https://t.co/ISx4D7lsXh
March 20th 2019, 10:03am
AmericanBanking @AmericanBanking
Head to Head Review: Brainstorm Cell Therapeutics $BCLI & Atara Biotherapeutics $ATRA https://t.co/E55uMTGEzX #stocks
March 20th 2019, 10:03am
AnalystsAnalyst @AnalystsAnalyst
$BCLI Early Access to ALS Treatment in Israel https://t.co/E07oz8kD0y $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/casigKuS78
March 20th 2019, 9:03am
ahighelevation @ahighelevation
$BCLI Early Access to ALS Treatment in Israel https://t.co/q80lgiDiQm $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/DCJguA48sZ
March 20th 2019, 12:03am
thefinreviewer @thefinreviewer
Reviewing Unity Biotechnology Inc. $BCLI's results https://t.co/ZAMBdJetBt
March 19th 2019, 8:03pm
zackcappsocial @zackcappsocial
$BCLI Early Access to ALS Treatment in Israel https://t.co/oDS6zl7m4A $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/dPnsYqb3Ku
March 19th 2019, 7:03pm
ContentCarnivor @ContentCarnivor
$BCLI Early Access to ALS Treatment in Israel https://t.co/ftme5xtvyV $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/BHWfL6J3ql
March 19th 2019, 6:03pm
BlogYomi @BlogYomi
Comparing of Millendo Therapeutics Inc. $BCLI https://t.co/sDWkfJSCXu
March 19th 2019, 6:03pm
ZacksAwareness @ZacksAwareness
$BCLI Early Access to ALS Treatment in Israel https://t.co/CbYaca91a6 $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/Dq4UdCOBGF
March 19th 2019, 6:03pm
HowieRegay @HowieRegay
$BCLI Early Access to ALS Treatment in Israel https://t.co/pD18tCcpKy $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/CIvuZdkSer
March 19th 2019, 3:03pm
stocknewstimes @stocknewstimes
$1.50 Million in Sales Expected for Brainstorm Cell Therapeutics Inc $BCLI This Quarter https://t.co/jpqBHhHnUK
March 19th 2019, 3:03am
AmericanBanking @AmericanBanking
$1.50 Million in Sales Expected for Brainstorm Cell Therapeutics Inc $BCLI This Quarter https://t.co/rsfnZiLiHf #stocks
March 19th 2019, 3:03am
TranscriptDaily @TranscriptDaily
$1.50 Million in Sales Expected for Brainstorm Cell Therapeutics Inc $BCLI This Quarter https://t.co/9HTRWhPK2I
March 19th 2019, 3:03am
BlogYomi @BlogYomi
Comparing of Savara Inc. $BCLI https://t.co/q4jvoyBISa
March 18th 2019, 8:03pm
thefinreviewer @thefinreviewer
Reviewing Biohaven Pharmaceutical Holding Company Ltd. $BCLI's results https://t.co/yssd1yZ6hi
March 18th 2019, 2:03am
AnalystsAnalyst @AnalystsAnalyst
$BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/LqfOZyFj2Z $BCLI @BrainstormCell #biotech… https://t.co/fu6akd9ef6
March 17th 2019, 12:03pm
ZacksAwareness @ZacksAwareness
$BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/N44PpDZteQ $BCLI @BrainstormCell #biotech… https://t.co/h24rjpqcbo
March 17th 2019, 11:03am
HowieRegay @HowieRegay
$BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/xmghV87coF $BCLI @BrainstormCell #biotech… https://t.co/npg5PYc0rc
March 17th 2019, 11:03am
ContentCarnivor @ContentCarnivor
$BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/tqDyizy40i $BCLI @BrainstormCell #biotech… https://t.co/7EqvY6x2ya
March 17th 2019, 10:03am
alsadvocacy @alsadvocacy
Our arithmetic challenge... What is @BrainstormCell $BCLI thinking? Hmmm... Number of potential patients in appro… https://t.co/qP9wIjMYo7
March 17th 2019, 8:03am
TranscriptDaily @TranscriptDaily
Analysts Anticipate Brainstorm Cell Therapeutics Inc $BCLI to Announce -$0.10 Earnings Per Share https://t.co/OJOHAl5Rb3
March 17th 2019, 6:03am
AmericanBanking @AmericanBanking
Analysts Anticipate Brainstorm Cell Therapeutics Inc $BCLI to Announce -$0.10 Earnings Per Share https://t.co/ym0l4hliwx #stocks
March 17th 2019, 6:03am
ahighelevation @ahighelevation
$BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/N8eXpy5ky4 $BCLI @BrainstormCell #biotech… https://t.co/Oi54SmZNbq
March 17th 2019, 12:03am
zackcappsocial @zackcappsocial
$BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/cmV7iQRcuI $BCLI @BrainstormCell #biotech… https://t.co/tjRYuBalFu
March 16th 2019, 10:03pm
risk_averse_ @risk_averse_
$BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/y24UtKD5cU $BCLI @BrainstormCell #biotech… https://t.co/HsphzjekwH
March 16th 2019, 9:03pm
TheTruthStudio @TheTruthStudio
$BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/xj8vlVZ3Jo $BCLI @BrainstormCell #biotech… https://t.co/ESq7jvMPHk
March 16th 2019, 8:03pm
zackcapp @zackcapp
$BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/LKvI8Jjtmf $BCLI @BrainstormCell #biotech… https://t.co/bYUoUOeRbw
March 16th 2019, 8:03pm
InstitutionalZC @InstitutionalZC
$BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/asVoD4h685 $BCLI @BrainstormCell #biotech… https://t.co/M6BjMMopI3
March 16th 2019, 8:03pm
ResearchPool @ResearchPool
$BCLI #Brainstorm Cell Therapeutics BCLI: Hospital Exemption Approved in Israel; First Patient Enrolled in Phase 2… https://t.co/hkxg2MEOk3
March 15th 2019, 9:03pm
ZacksSmallCap @ZacksSmallCap
$BCLI: @BrainstormCell Early Access to ALS Treatment in Israel - https://t.co/VSe8y85PtT by @DavidBautz
March 15th 2019, 10:03am
MaisaCorp @MaisaCorp
$BCLI Initiates Enrollment in Mid-Stage Trial of Progressive Multiple Sclerosis
March 14th 2019, 4:03pm
StockNewsNow @StockNewsNow
$BCLI BrainStorm Announces First Patient Enrolled in Phase 2 Clinical Trial of Progressive MS https://t.co/grPICK8vxA
March 14th 2019, 11:03am
whatsonthorold2 @whatsonthorold2
What’s Propelling Brainstorm Cell Therapeutics Inc $BCLI After Lower Shorts Reported? https://t.co/WVez4rwH9S
March 14th 2019, 9:03am
bthefirsttoknow @bthefirsttoknow
$BCLI BrainStorm Announces First Patient Enrolled in P..... https://t.co/6MzH7YvHX7
March 14th 2019, 2:03am
newswithvalue @newswithvalue
$BCLI: BrainStorm Announces First Patient Enrolled in Phase 2 Clinical …: https://t.co/VajgyidloX
March 14th 2019, 1:03am
StockTexts @StockTexts
$BCLI BrainStorm Announces First Patient Enrolled in Phase 2 Clinical Trial of Progressive MS Nasdaq:BCLI https://t.co/DtOSrNqHMB
March 14th 2019, 1:03am
mmahotstuff1 @mmahotstuff1
TOday’s Movers: Brainstorm Cell Therapeutics $BCLI Stock Rating Reaffirmed by Maxim Group; $9 Target Price Indicate… https://t.co/W6DD8cdJPd
March 13th 2019, 10:03pm
whatsonthorold2 @whatsonthorold2
Analysts at Maxim Group Maintained their Past ‘"Buy"’ rating on Shares Brainstorm Cell Therapeutics $BCLI, Set a $9… https://t.co/ycy2hNAcFr
March 13th 2019, 10:03pm
bibeypost_stock @bibeypost_stock
Brainstorm Cell Therapeutics $BCLI: Maxim Group Reaffirms Buy Rating Today, Has a Target of $9/Share https://t.co/cGmxwDCX5L
March 13th 2019, 10:03pm
reurope_stock @reurope_stock
TOday’s Movers: Brainstorm Cell Therapeutics $BCLI Stock Rating Kept by Analysts at Maxim Group; $9 Target Price In… https://t.co/BUos97QeYC
March 13th 2019, 10:03pm
bulletin_en @bulletin_en
Brainstorm Cell Therapeutics Inc $BCLI Shorts Reduced By 1.09% https://t.co/NeCnvDJUjw
March 13th 2019, 5:03pm
StockNewsNow @StockNewsNow
$BCLI #VIDEO: BrainStorm Cell Therapeutics - Developing Cellular Therapies for Neurodegenerative Diseases… https://t.co/fF2apaOtoo
March 13th 2019, 11:03am
FinZTribune @FinZTribune
Anticipated $-0.13 EPS for Brainstorm Cell Therapeutics Inc. $BCLI as of March, 14 https://t.co/VvrVw3M4HZ
March 13th 2019, 7:03am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.